RecruitingNCT06590467

Abbott Structural Heart Device Registry


Sponsor

Abbott Medical Devices

Enrollment

2,500 participants

Start Date

Aug 21, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The Abbott Structural Heart (SH) Registry is being conducted to confirm the safety and performance of Abbott's SH devices in a post-market, real-world setting. The Registry primarily involves gathering data from routine hospital practices and standard-of-care (SOC) procedures administered to patients. All devices used in these procedures must be commercially available to the participating site. A list of specific devices covered by the Registry are available upon request from the Sponsor. Data generated by the Registry will be used to meet regulatory requirements, such as the European Union Medical Device Regulations 2017/745, that require active post-market clinical follow-up (PMCF) for all commercially available devices.


Eligibility

Inclusion Criteria3

  • Subject is expected to undergo an implant attempt using one or more Abbott Structural Heart devices covered in this Registry or has previously undergone an implant attempt within the timeframes specified in the device-specific appendices.
  • Subject is willing and able to comply with the site's standard of care follow-up schedule.
  • Subject is willing to provide appropriate informed consent for Registry participation. For deceased subjects enrolled retrospectively, local regulations and EC/IRB recommendations regarding consent and the protection of personal data must be followed.

Exclusion Criteria1

  • \. Subject is participating in another clinical study that would affect the results of this Registry.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAmplatzer™ Occlusion Devices

The Amplatzer™ Occluders are devices intended for the occlusion of multiple septal heart defects.

DEVICEEpic™ Surgical Tissue Heart Valve devices

The Epic™ valves are indicated for patients requiring replacement of a diseased, damaged, or malfunctioning native aortic/mitral heart valve. It may also be used as a replacement for a previously implanted aortic/mitral prosthetic heart valve.


Locations(27)

Robert Wood Johnson University Hospital

New Brunswick, New Jersey, United States

Mount Sinai Hospital

New York, New York, United States

UPMC

Pittsburgh, Pennsylvania, United States

Sentara Norfolk General Hospital

Norfolk, Virginia, United States

Odense University Hospital

Odense, Southern Denmark, Denmark

Tartu University Hospital

Tartu, Tartu, Estonia

CHRU Hopital de Pontchaillou

Rennes, Brittan, France

Centre Médico Chirurgical Marie Lannelongue

Le Plessis-Robinson, France

Hopital Haut Leveque

Pessac, France

Deutsches Herzzentrum München des Freistaates Bayern

München, Bavaria, Germany

Klinikum Links der Weser

Bremen, City state Bremen, Germany

Universitatsklinikum Jena

Jena, Germany, Germany

Städt. Klinikum Braunschweig gGmbH

Braunschweig, L Saxon, Germany

Deutsches Herzzentrum der Charité

Berlin, State of Berlin, Germany

Schüchtermann-Schiller´sche Kliniken GmbH & Co. KG

Bad Rothenfelde, Germany

Children's Health Ireland (CHI)

Crumlin, Dublin, Ireland

IRCCS Policlinico San Donato - Cardio

San Donato Milanese, Lombardy, Italy

Policlinico San Donato

San Donato Milanese, Lombardy, Italy

A.O.U. Citta della Salute e della Scienza di Torino

Turin, Piedmont, Italy

Azienda Ospedaliero Universitaria Pisana

Pisa, Tuscany, Italy

Slaskie Centrum Chorob Serca

Zabrze, Silesian Voivodeship, Poland

Hospital Infantil Sant Joan De Deu

Esplugues de Llobregat, Catalonia, Spain

Hospital Universitario Central de Asturias

Oviedo, Principality of Asturias, Spain

Hospital Virgen de Rocio

Seville, Spain, Spain

Hospital Universitario de la Paz - Pediatrico

Madrid, Spain

Royal Brompton Hospital

London, UK, United Kingdom

St. Thomas Hospital

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06590467


Related Trials